September 6, 2019
BACK BAY EVENT CENTER
180 BERKELEY STREET
AM: The Future of Ophthalmology
PM: Ethics and Risk Management
Click HERE for program
Click HERE to register
MESSAGE FROM THE PRESIDENT
Mary K. Daly, MD
Your attendance at this 776th meeting of the New England Ophthalmological Society is so welcome and meaningful to our organization. We are so excited to bring some new initiatives to our 135th year. Our membership has never been so diverse or talented. We are working hard to hear from you and ensure we are providing you with maximum value in our educational sessions as well as through our many committees which strive tirelessly to enhance your professional endeavors on behalf of patients throughout New England.
This Society is not just a professional one. It is a community which fosters friendships spanning decades, connecting generations, and which brings us all closer. A few of our new enterprises this year include the invitation of the incoming first year residents to the six New England academic programs (Yale, Brown, Tufts, University of Massachusetts, Boston University, Harvard University) to one of the 2019-2020 Speaker’s Dinners. They are our newest colleagues, and we welcome them to New England! We will be trying out a new venue space for the first time in ages. Change is important, and this new space on November 1st will be a great chance to explore a different location for our vendors and all of you. We are working to incorporate more social time into our meetings so you can spend more time catching up with colleagues you may not otherwise have the chance to see. With views of the Charles River and time and space for a membership lunch and end-of-the day reception, this new meeting location should prove the perfect place to try something new and foster time and atmosphere for great conversation and connections. We are also revamping our fundraising opportunities and donor levels. Donations are critical to our growth and success. We hope that these new sponsorship opportunities and recognitions for contributions to our Society will welcome new and exciting patronage and support which will help sustain us well into the future.
This academic year will bring us into the year 2020. That is a special year for us, a Society which works collectively to bring perfect vision to our patients whenever possible. It is a privilege to serve you, the membership. Please feel free to reach out to me directly. I welcome hearing from you and will work hard this year, as President, to live up to the high standards set by past-presidents, as well as to ensure NEOS is fulfilling your expectations and needs as an ophthalmologist in this great region we proudly call New England.
Dimitri Azar, MD, MBA
Dr. Dimitri Azar, M.D., MBA, in 2017, joined Alphabet Verily Life Sciences as Senior Director of Ophthalmic Innovations (including diagnostic, therapeutic, drug delivery and surgical innovations). He is Distinguished Professor of Ophthalmology, and served as Dean of the University of Illinois College Of Medicine from 2011 to 2018. Previously he was Professor of Ophthalmology and Director of the Cornea and Refractive Surgery Services at the Massachusetts Eye and Ear Infirmary and Harvard Medical School.
Dr. Azar was Independent Non-Executive Director of Novartis AG (2012-2019). He serves as a Member of Verily Advisory Board at Verily Life Sciences LLC.
He is an internationally recognized ophthalmic surgeon and prolific researcher. He has been named one of The Best Doctors in America and one of the Castle Connolly Top Doctors in America annually since 1994. He has held multiple committee positions with the American Academy of Ophthalmology, and was board member and Vice President of the Association of Research in Vision and Ophthalmology. He is a member of the American Ophthalmological Association and sits on the Board of Trustees of the Chicago Ophthalmological Society and the Chicago Medical Society.
He has published 450 papers and chapters, 22 textbooks and 40 patents. His work on Matrix Metalloproteinases in wound healing and angiogenesis has been continuously funded by the NIH R01 award sinceHe has received multiple leadership awards, including the Lans Distinguished Award from the International Society of Refractive Surgery and the Barraquer and Lifetime Achievement Awards from the American Academy of Ophthalmology. He holds a medical degree from the American University of Beirut, Lebanon, and an Honorary MA from Harvard University and an Executive MBA with high honors from the University of Chicago, Booth School of Business.
Maria Woodward, MD
Dr. Woodward is a physician-scientist focused on healthcare delivery specifically for the anterior segment of the eye. Her career goal is to dramatically extend high-quality, affordable eye care to underserved and under-represented communities nationally and globally. Funded by the National Eye Institute, her research has focused on novel ophthalmic technologies and eHealth clinical programs – particularly disease-monitoring tools with low acquisition and delivery costs. Her research goal is to personalize treatments earlier and more accurately in order to improve outcomes. She is the director of Telemedicine and Clinical Programs for the University of Michigan’s Kellogg Eye Center eHealth. She serves on the American Academy of Ophthalmology’s Research, Regulatory & External Scientific Relations Committee and American Academy of Ophthalmology’s Telemedicine Task Force. She collaborates with national and international leaders in telemedicine, cornea, health sciences, and engineering, including close collaboration with Aravind Eye Hospitals in India.
Dr. Woodward is a physician-scientist focused on healthcare delivery specifically for the anterior segment of the eye. Her career goal is to dramatically extend high-quality, affordable eye care to underserved and under-represented communities nationally and globally.
Funded by the National Eye Institute, her research has focused on novel ophthalmic technologies and eHealth clinical programs – particularly disease-monitoring tools with low acquisition and delivery costs. Her research goal is to personalize treatments earlier and more accurately in order to improve outcomes.
She is the director of Telemedicine and Clinical Programs for the University of Michigan’s Kellogg Eye Center eHealth. She serves on the American Academy of Ophthalmology’s Research, Regulatory & External Scientific Relations Committee and American Academy of Ophthalmology’s Telemedicine Task Force. She collaborates with national and international leaders in telemedicine, cornea, health sciences, and engineering, including close collaboration with Aravind Eye Hospitals in India.
She has extensive publications in the area of telemedicine, including the use of smartphones and electronic health record data to improve ophthalmic diagnosis. Her work has focused on the use of telemedicine for screening and consultation as well as patient attitudes towards telemedicine care. A cornea specialist, she has also published in the area of corneal transplantation and eye banking. She has served as an Associate Editor for the International Journal of Eye Banking, Cataract and Refractive Surgery and BMC Ophthalmology.
B. THOMAS HUTCHINSON
Dr. Thomas Hutchinson was born in Flatwoods, West Virginia. After graduating from West Virginia University where he was elected to Phi Beta Kappa, he received his medical degree from Harvard Medical School. Following internship at Pennsylvania Hospital in Philadelphia and two years in the Public Health Service, Dr. Hutchinson returned to Boston for a fellowship in the Howe Laboratory, Harvard Medical School, a residency in ophthalmology and a fellowship in glaucoma at the Massachusetts Eye and Ear Infirmary.
He is a founding partner of Ophthalmic Consultants of Boston. He is a past president of the American Academy of Ophthalmology, past chair of the Advisory Board of the Foundation of the AAO, and has served as a member of the AAO Board of Trustees and the Foundation Advisor Board. In addition, Dr. Hutchinson has served as the first Secretary of Ophthalmic Practice. He has served for 9 years as a director and one as chairman of the American Board of Ophthalmology as well as a director of OMIC.
As an Associate Clinical Professor of Ophthalmology at Harvard Medical School, he has for over 40 years maintained an active role in the teaching of medical students and residents. He has trained over 100 ophthalmic fellows in the subspecialty management of glaucoma and cataract. For many years he was the director of the Harvard Post-Graduate Course and for 10 years was the assistant chief editor of Archives of Ophthalmology. Dr. Hutchinson was a founding officer and is a past president of the Massachusetts Society of Eye Physicians and Surgeons, past president of the Society to Prevent Blindness-Massachusetts, and a past president of the New England Ophthalmological Society. He is also a member of the American Glaucoma Society and a founding director and past president of the Chandler-Grant Glaucoma Society. Dr. Hutchinson is the author of multiple peer reviewed articles, editorials, and book chapters, and has lectured extensively.
His professional interests also include quality assurance, credentialing and public service programs, and for 25 years Dr. Hutchinson was the founding Chairman of AAO’s Eye Care America, the largest public service program in American medicine.
Dr. Hutchinson has received multiple awards, including the AAO Senior Honor Award, the Lifetime Achievement Award, and the Distinguished Service Award, as well as being Guest of Honor at the Academy’s 100th anniversary. In addition, he has been Man of the Year from NEOS as well as numerous regional and national awards.
Dr. Hutchinson’s constant dedication to quality of care and ethical medicine has been a pillar of quality in local, regional and national ophthalmology.
Previous Hutchinson Lecturers
George A. Williams, MD - 2017
DISTINGUISHED ACHIEVEMENT AWARD RECIPIENT
Phil A. Aitken, MD
Phil Aitken epitomizes the kind of doctor we all want to have taking care of us if we have a medical problem. He is conscientious, thoughtful, intelligent and soft spoken.
Among Vermont ophthalmologists Phil is considered to be one of the best. He has been the glue that holds the Vermont Ophthalmological Society together. Phil was instrumental in organizing meetings and bringing in some of the best speakers in the nation. His dedication to education and learning is unparalleled.
Phil has been a member of NEOS since 1978. He has worked on many committees including: Program Committee, Executive Committee, Budget/Finance Committee, Admissions Committee, and Ophthalmic Services Committee. He has also given many lectures and moderated many sessions. Phil was President of NEOS in 1993-1994.
Phil is an active member of the American Academy of Ophthalmology. Over the past several decades he has dedicated his time and talents to many committees for this organization including serving six years on the AAO Ethics Committee. Phil is involved with education at a local, state, national and international level.
Phil was born in Friend, Nebraska with a population of 1000, “ When everyone was home.” He first attended Oregon State University and completed his college degree at Wheaton College in Illinois. He received his medical degree at Baylor College of Medicine. After an Internship and Neurology Residency at the University of Vermont, he served two years as a commissioned officer at the National Institutes of Health. Following this he completed an Ophthalmology residency at George Washington University. He then traveled to London to complete a Neuro-ophthalmology Fellowship at the National Hospital, Queen Square, and later an Oculoplastics Fellowship at Moorfield’s Hospital.
Phil was the founding chair of ophthalmology at the University of Vermont and served in that position for seventeen years. He has been involved in many research projects and published in many journals. An amazing testament to Phil’s love of ophthalmology and teaching is that he continues as a professor of ophthalmology and neurology and works as a neuro-ophthalmologist at the University of Vermont even into his latter years of life. Phil is a role model for both young and not so young ophthalmologists.